Medical and Health

During many years of cardiology practice, I (Dan) have noticed a broad variation in patient’s response to pharmacologic interventions. We have to recognize that even the most well proven medical therapies never have a perfect degree of effectiveness. As we became interested in CBD, I have become increasingly aware of patient’s mentioning its use, many with enthusiasm. To date, there are few well designed clinical trials of CBD, but there is a rapidly growing interest in evaluating this entity for a variety of disease processes. There is an FDA approved product for two specific types of seizures in children. There is hope that it will prove beneficial in spasticity associated with multiple sclerosis, anxiety, acute and chronic pain, dementia, and post-traumatic stress disorder. A clinical trial showed benefit in persons with sleep apnea, Crohn’s disease, Ulcerative Colitis, migraines, sleep disorders, neurological disorders and various dermatological disorders. There may turn out to be benefits in other conditions as well. There is also evidence that CBD can induce programed cell death or apoptosis in some types of human cancer cells. There is also some hope that it might reduce blood pressure and positively affect vessel health. An ongoing challenge is the fact that well designed clinical trials are quite costly. No single producer or vendor has had the incentive to take this on. Hopefully with time, groups will be able to combine resources to develop a clearer picture of the role CBD may play in the well-being in patients and healthy persons alike.